Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.07Cr 1Cr 91.82L 1.73Cr 117.67Cr 1.76Cr 12Cr 4.61Cr 59Cr 4.64Cr 4.54Cr 195.68Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.23Cr 2.09Cr 1.91Cr 3.61Cr 244.76Cr 3.65Cr 24Cr 9.59Cr 122.29Cr 9.65Cr 9.44Cr 407.03Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
3 months-25.00%
6 months+5.26%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-33.33% 74.12L
+0.68%+1.68%+28.41%+5.83% 21TCr
+1.02%+3.29%+1.46%-21.22% 14TCr
+1.44%+6.65%-19.79%+21.86% 13TCr
+1.02%+6.16%-51.82%-2.21% 7.14TCr
+0.50%+3.82%+14.67%+11.92% 5.15TCr
+1.13%+6.89%-14.66%-19.25% 5.02TCr
+1.27%+3.57%+25.73%+13.28% 3.99TCr
+0.14%+6.19%+44.13%+38.30% 3.92TCr
-4.84%-0.68%-25.21%+12.25% 3.22TCr
Average +0.23%+3.84%+5.29%+2.74% 7.72TCr
Weighted average by Cap. +0.71%+3.41%+2.53%+3.98%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.64L 7.9Cr 11.79L 78.86L 30.95L 3.95Cr 31.15L 30.47L 13Cr 16.09L 13.97L 13.08L 11.96L 22.59L 15Cr 22.88L 1.53Cr 60.05L 7.66Cr 60.43L 59.12L 25Cr
Net income -11.6L -10.06L -9L -9L -16.27L -11Cr -16.49L -1.1Cr -43.27L -5.52Cr -43.54L -42.6L -18Cr -3L -3L -2L -2L -4L -2.76Cr -4L -27.55L -10.81L -1.38Cr -10.88L -10.65L -4.59Cr
Net Debt 1.31Cr 1.13Cr 1.06Cr 97.14L 1.83Cr 124.48Cr 1.86Cr 12Cr 4.88Cr 62Cr 4.91Cr 4.8Cr 207.01Cr 1.33Cr 1.16Cr 1.08Cr 99.17L 1.87Cr 127.09Cr 1.9Cr 13Cr 4.98Cr 63Cr 5.01Cr 4.9Cr 211.35Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
07/26/07 $0.000300 0.00% 3,00,284
06/26/06 $0.000300 0.00% 2,24,21,881
05/26/05 $0.000300 0.00% 1,78,36,193
04/26/04 $0.000300 0.00% 28,22,980
03/26/03 $0.000300 0.00% 25,41,443
  1. Stock Market
  2. Stocks
  3. BIEL Stock